Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience

Background/objective There are no randomized trials on the comparative effectiveness of radical prostatectomy (RP) and radiotherapy (RT) for high-risk prostate cancer. Our aim was to compare treatment outcomes of high-risk prostate cancer after RP and RT, including overall survival (OS), biochemical...

Full description

Bibliographic Details
Main Authors: Albertas Ulys, Agne Ulyte, Pavel Dziameshka, Oleg Sukonko, Sergei Krasny, Sergei Polyakov, Giedre Smailyte
Format: Article
Language:English
Published: Vilnius University Press 2015-01-01
Series:Lietuvos Chirurgija
Subjects:
Online Access:http://www.journals.vu.lt/lietuvos-chirurgija/article/view/5106
_version_ 1823991295613337600
author Albertas Ulys
Agne Ulyte
Pavel Dziameshka
Oleg Sukonko
Sergei Krasny
Sergei Polyakov
Giedre Smailyte
author_facet Albertas Ulys
Agne Ulyte
Pavel Dziameshka
Oleg Sukonko
Sergei Krasny
Sergei Polyakov
Giedre Smailyte
author_sort Albertas Ulys
collection DOAJ
description Background/objective There are no randomized trials on the comparative effectiveness of radical prostatectomy (RP) and radiotherapy (RT) for high-risk prostate cancer. Our aim was to compare treatment outcomes of high-risk prostate cancer after RP and RT, including overall survival (OS), biochemical-progression-free survival (bPFS) and disease-progression-free survival (dPFS), using two cancer treatments centers’ patient data. Methods Data on high-risk prostate cancer patients between 2005 and 2009 were retrospectively reviewed in two cancer centers: National Cancer Institute, Vilnius, Lithuania and N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 210 patients were included in the study group treated with RP (n = 174) or RT (n = 36). The mean follow-up time was 5.6 and 6.6 years, respectively. Results Lower T stage was an independent predictor of better OS (p = 0.01) and bPFS (p = 0.03). Only the highest Gleason score ≥8 was significantly predictive of a worse OS (p = 0.05), bPFS (p = 0.02) and dPFS (p = 0.001). A high PSA level was predictive of a worse bPFS (p = 0.007 for PSA ≥20) and dPFS (p = 0.008 for ≥20). The treatment modality in this study was insignificant after T stage, Gleason score and PSA level adjustment for OS, bPFS survival and dPFS survival (p = 0.17, p = 0.39, p = 0.20). Conclusions The T stage, Gleason score and pretreatment PSA level are significant factors for OS, bPFS survival, and dPFS survival of highrisk prostate cancer patients. Treatment option (RP or RT) was not an independent predictor of survival in this study.
first_indexed 2024-12-18T15:52:04Z
format Article
id doaj.art-a092ea949c2a4bb291e9248b2e8bc0e8
institution Directory Open Access Journal
issn 1392-0995
1648-9942
language English
last_indexed 2024-12-18T15:52:04Z
publishDate 2015-01-01
publisher Vilnius University Press
record_format Article
series Lietuvos Chirurgija
spelling doaj.art-a092ea949c2a4bb291e9248b2e8bc0e82022-12-21T21:02:33ZengVilnius University PressLietuvos Chirurgija1392-09951648-99422015-01-01134Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experienceAlbertas UlysAgne UlytePavel DziameshkaOleg SukonkoSergei KrasnySergei PolyakovGiedre SmailyteBackground/objective There are no randomized trials on the comparative effectiveness of radical prostatectomy (RP) and radiotherapy (RT) for high-risk prostate cancer. Our aim was to compare treatment outcomes of high-risk prostate cancer after RP and RT, including overall survival (OS), biochemical-progression-free survival (bPFS) and disease-progression-free survival (dPFS), using two cancer treatments centers’ patient data. Methods Data on high-risk prostate cancer patients between 2005 and 2009 were retrospectively reviewed in two cancer centers: National Cancer Institute, Vilnius, Lithuania and N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 210 patients were included in the study group treated with RP (n = 174) or RT (n = 36). The mean follow-up time was 5.6 and 6.6 years, respectively. Results Lower T stage was an independent predictor of better OS (p = 0.01) and bPFS (p = 0.03). Only the highest Gleason score ≥8 was significantly predictive of a worse OS (p = 0.05), bPFS (p = 0.02) and dPFS (p = 0.001). A high PSA level was predictive of a worse bPFS (p = 0.007 for PSA ≥20) and dPFS (p = 0.008 for ≥20). The treatment modality in this study was insignificant after T stage, Gleason score and PSA level adjustment for OS, bPFS survival and dPFS survival (p = 0.17, p = 0.39, p = 0.20). Conclusions The T stage, Gleason score and pretreatment PSA level are significant factors for OS, bPFS survival, and dPFS survival of highrisk prostate cancer patients. Treatment option (RP or RT) was not an independent predictor of survival in this study.http://www.journals.vu.lt/lietuvos-chirurgija/article/view/5106high-risk prostate cancerradical prostatectomyradiotherapy
spellingShingle Albertas Ulys
Agne Ulyte
Pavel Dziameshka
Oleg Sukonko
Sergei Krasny
Sergei Polyakov
Giedre Smailyte
Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
Lietuvos Chirurgija
high-risk prostate cancer
radical prostatectomy
radiotherapy
title Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
title_full Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
title_fullStr Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
title_full_unstemmed Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
title_short Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
title_sort radical prostatectomy vs radiotherapy in high risk prostate cancer patients two centre experience
topic high-risk prostate cancer
radical prostatectomy
radiotherapy
url http://www.journals.vu.lt/lietuvos-chirurgija/article/view/5106
work_keys_str_mv AT albertasulys radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience
AT agneulyte radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience
AT paveldziameshka radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience
AT olegsukonko radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience
AT sergeikrasny radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience
AT sergeipolyakov radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience
AT giedresmailyte radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience